Exploring Bispecific Antibodies in Myeloma and Lymphoma

This chapter features a lively discussion of educational anecdotes and a pivotal publication on cytokine release syndrome related to bispecific antibodies. The speakers examine the current landscape of bispecific therapies, detailing approved treatments for myeloma and lymphoma, and the evolving practices in their usage. They delve into the complexities of treatment strategies, highlighting the necessity of careful patient monitoring and the implications of emerging therapies.